← Back
$BCRX All transactions

BIOCRYST PHARMACEUTICALS INC

A

$ Value

$0

Shares

147,000

Price

$0

Filed

Jul 28

Insider

Name

Ghias Babar

Title

CFO & Head of Corp Development

CIK

0002076862

Roles

Officer

Transaction Details

Transaction Date

2025-07-24

Code

A

Table

Non-Derivative

Ownership

Direct

Equity Swap

No

Shares After

147,000

Footnotes

Inducement grant of restricted stock units pursuant to the BioCryst Pharmaceuticals, Inc. Stock Incentive Plan, as amended and restated (the "Stock Incentive Plan"), which will vest 25% on each of the first, second, third and fourth anniversaries of the date of grant. | Inducement grant of employee stock options pursuant to the Stock Incentive Plan, which will become exercisable at the rate of 25% on each of the first, second, third and fourth anniversaries of the date of grant.

Filing Info

Accession No.

0001127602-25-019632

Form Type

4

Issuer CIK

0000882796

Ghias Babar's History

Date Ticker Type Value
2025-12-17 BCRX A $0
2025-12-17 BCRX A $0
2025-07-24 BCRX A $0
2025-07-24 BCRX A $0

Other Insiders at BCRX (90d)

Insider Bought Sold Last
MILANO VINCENT 2026-02-27
Stonehouse Jon P 2026-03-02
Frank Steven 2026-02-27
Barnes Alane P
Chief Legal Officer
$1.4M 2026-03-16
Milne Jill C. 2026-02-27
HEGGIE THERESA $505K 2026-03-20
McKee Amy E 2026-02-27
Menon Sandeep
Chief R&D Officer
2026-04-06